Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study

J Infect Dis. 2023 May 12;227(10):1173-1184. doi: 10.1093/infdis/jiac437.

Abstract

Background: Humoral immune responses may be critical for preventing, controlling, and/or eliminating human papillomavirus (HPV) infection. We analyzed humoral response to natural HPV infection considering phylogenetic relatedness among unvaccinated women.

Methods: We included 399 young women attending university/college in Montreal, Canada who were participants of the HITCH cohort. Participants provided blood samples at baseline and 5 follow-up visits. Antibody response to bacterially expressed L1 and E6 glutathione S-transferase (GST) fusion proteins, and virus-like particles (VLP-L1) of Alphapapillomavirus types were measured using multiplex serology. We assessed correlations and associations between HPV types at baseline using Pearson correlation coefficients (r) and univariable linear regressions.

Results: At baseline, > 40% were seropositive for GST-L1 antibodies of at least 1 HPV type. Strong correlations between GST-L1 were observed for α9 HPV types: 58-52 (r = 0.86), 58-33 (r = 0.75), 33-52 (r = 0.72), and between GST-E6: 52-11 (r = 0.84), 52-18 (r = 0.79), 58-33 (r = 0.78), 35-11 (r = 0.76). HPV16 VLP-L1 moderately explained variability in HPV16 GST-L1 (regression coefficient [b] = 0.38, R2 = 43.1%), and HPV45 GST-L1 in HPV18 GST-L1 (b = 0.68, R2 = 42.8%). GST-E6 antibodies accounted for a low to moderate proportion of variability in HPV16 and HPV18 GST-E6 (R2 = 6.4%-62.2%).

Conclusions: Associations between naturally induced HPV-specific antibodies depend on phylogenetic relatedness.

Keywords: antibodies; human papillomavirus; humoral immunity; serology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • Capsid Proteins / genetics
  • Cohort Studies
  • Female
  • Genotype
  • Human Papillomavirus Viruses
  • Human papillomavirus 16
  • Humans
  • Oncogene Proteins, Viral* / genetics
  • Papillomavirus Infections*
  • Papillomavirus Vaccines*
  • Phylogeny

Substances

  • Antibodies, Viral
  • Capsid Proteins
  • Oncogene Proteins, Viral
  • Papillomavirus Vaccines

Supplementary concepts

  • human papillomavirus 45